Search

Smart wearables provide an opportunity to monitor health in daily life and are emerging as potential tools for detecting cardiovascular disease (CVD). Wearables such as fitness bands and smartwatches routinely monitor the photoplethysmogram signal, an optical measure of the arterial pulse wave that is strongly influenced by the heart and blood vessels. In this survey, we summarize the fundamentals of wearable photoplethysmography and its analysis, identify its potential clinical applications, and outline pressing directions for future research in order to realize its full potential for tackling CVD., This work was supported by British Heart Foundation grants [PG/15/104/31913] and [FS/20/20/34626], the University of Cambridge EPSRC Impact Acceleration Account, the Wellcome EPSRC Centre for Medical Engineering at King’s College London [WT 203148/Z/16/Z], the European COST ACTION-Network for Research in Vascular Ageing CA18216 supported by COST (European Cooperation in Science and Technology), and the European Regional Development Fund (project No. 01.2.2-LMTK- 718-01-0030) under a grant agreement with the Research Council of Lithuania (LMTLT). The authors acknowledge: financial support from the Department of Health through the National Institute for Health Research Cardiovascular MedTech Co-operative at Guy’s and St Thomas’ NHS Foundation Trust.

Peer reviewed: True, Intervals of low-quality photoplethysmogram (PPG) signals might lead to significant inaccuracies in estimation of pulse arrival time (PAT) during polysomnography (PSG) studies. While PSG is considered to be a "gold standard" test for diagnosing obstructive sleep apnea (OSA), it also enables tracking apnea-related nocturnal blood pressure fluctuations correlated with PAT. Since the electrocardiogram (ECG) is recorded synchronously with the PPG during PSG, it makes sense to use the ECG signal for PPG signal-quality assessment. (1) Objective: to develop a PPG signal-quality assessment algorithm for robust PAT estimation, and investigate the influence of signal quality on PAT during various sleep stages and events such as OSA. (2) Approach: the proposed algorithm uses R and T waves from the ECG to determine approximate locations of PPG pulse onsets. The MESA database of 2055 PSG recordings was used for this study. (3) Results: the proportions of high-quality PPG were significantly lower in apnea-related oxygen desaturation (matched-pairs rc = 0.88 and rc = 0.97, compared to OSA and hypopnea, respectively, when p < 0.001) and arousal (rc = 0.93 and rc = 0.98, when p < 0.001) than in apnea events. The significantly large effect size of interquartile ranges of PAT distributions was between low- and high-quality PPG (p < 0.001, rc = 0.98), and regular and irregular pulse waves (p < 0.001, rc = 0.74), whereas a lower quality of the PPG signal was found to be associated with a higher interquartile range of PAT across all subjects. Suggested PPG signal quality-based PAT evaluation reduced deviations (e.g., rc = 0.97, rc = 0.97, rc = 0.99 in hypopnea, oxygen desaturation, and arousal stages, respectively, when p < 0.001) and allowed obtaining statistically larger differences between different sleep stages and events. (4) Significance: the implemented algorithm has the potential to increase the robustness of PAT estimation in PSG studies related to nocturnal blood pressure monitoring.

Growing evidence shows that alcohol triggers paroxysmal atrial fibrillation (PAF) in some patients. However, there is a lack of methods for assessing the causality between triggers and atrial fibrillation (AF) episodes. Accordingly, this work aims to develop an approach to episode modeling under the influence of alcohol for the purpose of evaluating causality assessment methods. The alternating, bivariate Hawkes model is used to produce episode patterns, where the conditional intensity function λ1(t) defines the transitions from sinus rhythm (SR) to AF. The effect of alcohol consumption is characterized by a body reactivity function, defined by the base intensity μ1(t), which alters λ1(t). Different AF episode patterns were modeled for alcohol units ranging from 0 to 15. The mean AF burden without alcohol was 17.2%, which doubled with 9 alcohol units; the number of AF episodes doubled from 12.9 with 8 alcohol units. The aggregation of AF episodes tended to decrease after 6 alcohol units. The proposed model of alcohol-affected PAF patterns may be useful for assessing the methods for evaluation of causality between triggers and PAF occurrence.